DELPHX CAPITAL MARKETS INC (DELX.CA) Fundamental Analysis & Valuation

TSX-V:DELX • CA24721L1013

Current stock price

0.045 CAD
0 (0%)
Last:

This DELX.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. DELX.CA Profitability Analysis

1.1 Basic Checks

  • DELX had negative earnings in the past year.
  • DELX had a negative operating cash flow in the past year.
  • DELX had negative earnings in each of the past 5 years.
  • In the past 5 years DELX always reported negative operating cash flow.
DELX.CA Yearly Net Income VS EBIT VS OCF VS FCFDELX.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -2M -4M -6M -8M

1.2 Ratios

  • DELX has a worse Return On Assets (-1753.95%) than 96.15% of its industry peers.
Industry RankSector Rank
ROA -1753.95%
ROE N/A
ROIC N/A
ROA(3y)-1603.25%
ROA(5y)-1093.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
DELX.CA Yearly ROA, ROE, ROICDELX.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for DELX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
DELX.CA Yearly Profit, Operating, Gross MarginsDELX.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

0

2. DELX.CA Health Analysis

2.1 Basic Checks

  • Compared to 1 year ago, DELX has more shares outstanding
  • The number of shares outstanding for DELX has been increased compared to 5 years ago.
  • DELX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
DELX.CA Yearly Shares OutstandingDELX.CA Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
DELX.CA Yearly Total Debt VS Total AssetsDELX.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

2.2 Solvency

  • Based on the Altman-Z score of -419.29, we must say that DELX is in the distress zone and has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of -419.29, DELX is doing worse than 89.74% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -419.29
ROIC/WACCN/A
WACCN/A
DELX.CA Yearly LT Debt VS Equity VS FCFDELX.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 -2M -4M

2.3 Liquidity

  • DELX has a Current Ratio of 0.06. This is a bad value and indicates that DELX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DELX has a worse Current ratio (0.06) than 93.59% of its industry peers.
  • DELX has a Quick Ratio of 0.06. This is a bad value and indicates that DELX is not financially healthy enough and could expect problems in meeting its short term obligations.
  • DELX's Quick ratio of 0.06 is on the low side compared to the rest of the industry. DELX is outperformed by 93.59% of its industry peers.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06
DELX.CA Yearly Current Assets VS Current LiabilitesDELX.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 1M 2M 3M 4M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

0

3. DELX.CA Growth Analysis

3.1 Past

  • DELX shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.64%, which is quite impressive.
EPS 1Y (TTM)40.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.86%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocksShow best growing peers

0

4. DELX.CA Valuation Analysis

4.1 Price/Earnings Ratio

  • DELX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
DELX.CA Price Earnings VS Forward Price EarningsDELX.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
DELX.CA Per share dataDELX.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share -0 -0 -0.01 -0.01 -0.01

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. DELX.CA Dividend Analysis

5.1 Amount

  • No dividends for DELX!.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

DELX.CA Fundamentals: All Metrics, Ratios and Statistics

DELPHX CAPITAL MARKETS INC

TSX-V:DELX (3/18/2026, 7:00:00 PM)

0.045

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryCapital Markets
Earnings (Last)12-01
Earnings (Next)N/A
Inst Owners13.59%
Inst Owner ChangeN/A
Ins Owners7.49%
Ins Owner ChangeN/A
Market Cap9.81M
Revenue(TTM)N/A
Net Income(TTM)-2.73M
Analysts0
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.01
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.01
FCFYN/A
OCF(TTM)-0.01
OCFYN/A
SpS0
BVpS-0.01
TBVpS-0.01
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -1753.95%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-1603.25%
ROA(5y)-1093.88%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score6
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z -419.29
F-Score6
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)40.64%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%56.86%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y37.69%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y9.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y9.03%
OCF growth 3YN/A
OCF growth 5YN/A

DELPHX CAPITAL MARKETS INC / DELX.CA Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for DELPHX CAPITAL MARKETS INC?

ChartMill assigns a fundamental rating of 0 / 10 to DELX.CA.


Can you provide the valuation status for DELPHX CAPITAL MARKETS INC?

ChartMill assigns a valuation rating of 0 / 10 to DELPHX CAPITAL MARKETS INC (DELX.CA). This can be considered as Overvalued.


Can you provide the profitability details for DELPHX CAPITAL MARKETS INC?

DELPHX CAPITAL MARKETS INC (DELX.CA) has a profitability rating of 0 / 10.


Can you provide the financial health for DELX stock?

The financial health rating of DELPHX CAPITAL MARKETS INC (DELX.CA) is 0 / 10.